ORGO - Organogenesis Phase 3 ReNu OA study meets primary endpoint
2024-05-02 11:56:00 ET
More on Organogenesis Holdings
- Organogenesis Holdings, Inc. (ORGO) Q4 2023 Earnings Call Transcript
- Cantor starts Organogenesis at overweight, cites differentiated portfolio
- Seeking Alpha’s Quant Rating on Organogenesis Holdings
- Historical earnings data for Organogenesis Holdings
- Financial information for Organogenesis Holdings